Metsera spends $290 million to develop next-generation weight loss products
Photo credit: Visual Mozart/Getty Images Next-generation weight loss drug developer Metsera just Start-up capital is US$290 million. Backed by Population Health Partners and ARCH Venture Partners, and led by former …